Sangamo Therapeutics, Inc.
SGMO
$0.15
-$0.02-12.73%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.59M | 20.95M | 29.62M | 38.34M | 25.18M |
| Total Receivables | 6.36M | 10.51M | 5.13M | 4.98M | 4.61M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.16M | 4.37M | 8.42M | 6.57M | 7.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 912.00K | -- | -- |
| Total Current Assets | 37.11M | 35.83M | 44.08M | 49.89M | 37.60M |
|
|
|||||
| Total Current Assets | 37.11M | 35.83M | 44.08M | 49.89M | 37.60M |
| Net Property, Plant & Equipment | 13.22M | 14.11M | 29.22M | 30.79M | 32.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.63M | 9.81M | 15.35M | 16.87M | 15.73M |
| Total Assets | 59.97M | 59.75M | 88.64M | 97.56M | 86.17M |
|
|
|||||
| Total Accounts Payable | 19.31M | 14.44M | 15.56M | 10.74M | 18.20M |
| Total Accrued Expenses | 33.43M | 25.43M | 27.01M | 29.36M | 23.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 1.70M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 402.00K | 899.00K | 7.56M | 7.56M | 7.56M |
| Total Other Current Liabilities | 402.00K | 899.00K | 7.56M | 7.56M | 7.56M |
| Total Current Liabilities | 53.13M | 42.47M | 50.13M | 47.66M | 49.56M |
|
|
|||||
| Total Current Liabilities | 53.13M | 42.47M | 50.13M | 47.66M | 49.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.33M | 25.09M | 25.42M | 23.46M | 24.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.45M | 6.45M | 6.85M | 6.84M | 6.82M |
| Total Liabilities | 78.92M | 74.01M | 82.40M | 77.96M | 81.26M |
|
|
|||||
| Common Stock & APIC | 1.64B | 1.61B | 1.60B | 1.58B | 1.55B |
| Retained Earnings | -1.66B | -1.63B | -1.59B | -1.55B | -1.53B |
| Treasury Stock & Other | -2.51M | -1.46M | -1.45M | -1.46M | -5.53M |
| Total Common Equity | -18.96M | -14.27M | 6.24M | 19.60M | 4.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.96M | -14.27M | 6.24M | 19.60M | 4.91M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.96M | -14.27M | 6.24M | 19.60M | 4.91M |
|
|
|||||